Bone Bulletin



Total Hip Arthroplasty (THA) is a rapidly growing field within the United States. In 2023 alone, 1,050,821 arthroplasties were performed, making it the second-most performed arthroplasty of the year.1 With over a million of these procedures completed each year, there are several medical device companies that create their own implants to be used in these procedures. Each company can patent their own device and go through a thorough process involving the FDA to receive approval provided there is evidence from clinical trials that demonstrates their device improves patient outcomes.2 With the many implant options available, one question to consider is whether a specific medical device, compared to another one, is more prone to better patient outcomes in surgical operations. This review aims to provide information about the process of selecting the optimal hip prosthesis for a total hip arthroplasty candidate and include whether certain implants lead to better patient outcomes than others.

Included in

Orthopedics Commons